We are Australia's Life Sciences Innovation Accelerator. We are Australia's Life Sciences Innovation Accelerator championing the continuing growth of Australia's vibrant medical products sector. Connect with our newsletter: https://www.mtpconnect.org.au/newsletter Subscribe to our podcast: https://podcasts.apple.com/au/podcast/the-mtpconnect-podcast/id1453637211 Medical technology, Biotechnology, Pharmaceutical, Collaboration, and Commercialisation

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech healthtech biotech

Accelerate Biotechnology Batavia Biosciences is a science-based CDMO that offers personalized services that fully support all the stages of biopharmaceutical development, from cloning to GMP manufacture and release of clinical material for phase I/II studies. We are not your standard CDMO - our customers regularly refer to us as their product development partner and thought partner. We focus on the early stages of product development with services ranging from DNA cloning, mammalian cell line generation, upstream process development, purification development, product characterization to clinical manufacturing. Headquartered in Leiden, The Netherlands, Batavia Biosciences is privileged to have strong strategic partners in …

Type: Startup Activities: deeptech Technologies: Synthetic Biology

The leading global platform for decentralized clinical trials. Medable's mission is to get effective therapies to patients faster. We provide an end-to-end, global cloud platform with a flexible suite of tools that allows sponsors, patients, providers & CRO's to work together as a team in clinical trials. Our solutions enable more efficient clinical research, more effective healthcare delivery, and more accurate precision and predictive medicine. Our vision is to accelerate the path to human discovery and medical cures. We are passionate about driving innovation and empowering consumers. We are proactive, collaborative, self-motivated learners, committed, bold and tenacious. We are dedicated …

Type: Startup Activities: healthtech it services Technologies: A.I. A.I. - Machine Learning IoT SaaS

The leading digital media covering global biotech innovation Labiotech.eu is the leading digital media covering the global biotech industry. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. Join them now and enjoy reading our stories! "We are building the Next Generation of Digital Media for Biotech"​ Philip & Joachim, Founders of Labiotech.eu Biotechnology, Life science, News, and Media

Type: Media

Patient-based drug discovery We design and apply unique patient-based cellular assays for large-scale phenotypic screening, leaning on the power of AI-driven image analysis. Integrated from bed to bench and back to bed, we aim to generate most efficient first-in-class therapeutic molecules for next generation medicine. AI image and data analysis, biology, high content screening, high throughput screening, deep learning, assay development, patient stratification, pyschiatric disorders, and cardiac muscle

Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. Synthetic Biology

Bring rapid protein access to your benchtop with eProtein Discovery At Nuclera, our mission is to better human health by making proteins accessible. We believe that providing rapid access to high-quality, soluble, active proteins at the benchtop will allow researchers to accelerate their protein projects. Fail fast, succeed faster. Our eProtein DiscoveryTM system automates construct screening for the best soluble expression and purification yields of different proteins in under 24 hours. From there, protein scale-up happens the next day (up to the mg scale) right on the benchtop - delivering reliable protein in-hand in less than 48 hours. Nuclera’s technology …

Type: Startup Activities: biotech Technologies: Synthetic Biology

evaxion.ai Evaxion Biotech A/S is a pioneering TechBio company based upon its AI platform, AI-ImmunologyTM. Evaxion’s proprietary and scalable AI prediction models harness the power of artificial intelligence to decode the human immune system and develop novel immunotherapies for cancer, bacterial diseases, and viral infections. Based upon AI-ImmunologyTM, Evaxion has developed a clinical-stage oncology pipeline of novel personalized vaccines and a preclinical infectious disease pipeline in bacterial and viral diseases with high unmet medical needs. Evaxion is committed to transforming patients’ lives by providing innovative and targeted treatment options. For more information about Evaxion and its groundbreaking AI-ImmunologyTM platform and …

Type: Startup Activities: deeptech biotech Technologies: A.I. Synthetic Biology

The world's insight network GLG is the world’s largest insight network. We connect decision makers to the right experts so they can act with the confidence that comes from true clarity and have what it takes to get ahead. Our network of experts is the world’s largest source of first-hand expertise, and we recruit hundreds of new experts every day. We bring the power of insight to every great professional decision. Visit GLGinsights.com. For information regarding GLG’s practices with respect to personal information, please visit our privacy policy at https://glginsights.com/privacy-policy/ Professional Learning, Phone Consultations, Meetings, Roundtables, Site Visits, Strategic Projects, …

Type: Large company

Immunic is a biotechnology company developing small molecule therapies for chronic inflammatory and autoimmune diseases Immunic (Nasdaq: IMUX) is a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases. Privacy Policy: https://imux.com/privacy-policy/

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Customized phage therapies to eradicate harmful bacteria in chronic diseases BiomX (NYSE America: PHGE) is developing both natural and engineered phage cocktails and personalized treatments designed to target and destroy harmful bacteria in chronic diseases, including cystic fibrosis and diabetic foot osteomyelitis. BiomX discovers and validates proprietary bacterial targets and customizes phage compositions against these targets. Microbiome, Biotechnology, Drug Discovery, Phage Therapies, and Pharma

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Developing next-generation immunotherapies for cancer patients! Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives. Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience

Type: Startup Activities: biotech deeptech

Research, development and investment hub to accelerate cancer research in Quebec Research, development and investment hub to accelerate the fight against cancer.

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech

Deep Innovation on Adiposse Tissue. Research Partner from the Cell to Humans DIVA. Expertise is an consultancy, strategy and development company in scientific research in the fields of health, nutrition, cosmetics and aesthetics. Its objectives are to support manufacturers in the structuring, organization and development of their research in order to optimize its costs, deadlines and results. Personalized support by our experts energizes the R & Amp; D process of a product by promoting creativity, innovation and collaboration. His heart of expertise is targeted on the biology of the fatty fatty fabric, recognized as an endocrine organ with a fundamental …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

Pioneering thymus-empowered T-cell platform to fight cancer and infection Smart Immune is a clinical-stage French biotechnology company developing ProTcell, a thymus-empowered T cell progenitor platform to fully and rapidly re-arm the immune system against cancer and infection, enabling next-generation allogeneic T cell therapies. The company aims to radically improve outcomes for patients in hematology and immune-oncology. Smart Immune has ongoing collaborations with leading institutions in the US and Europe. SMART101 is in Phase I/II clinical trials in cancer patients with AML and ALL, in SCID in the EU and the US. Smart Immune is also developing therapies using gene-modified T …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Climfeet insoles can heat or cool your feet without further energy than your own footsteps SoleCooler aims the market of protection of the feet and hands, against severe cold or hot weather. The principle adopted by the SoleCooler's patent is based on thermodynamics and in particular on the Carnot cycle. Air is firstly compressed. During compression, the air heats up naturally (it's like warming up as you watch your bicycle pump). Once compressed, the air is expanded through the nozzle and cools naturally (like when you deflate your car tire: the air coming out is much colder while the tire …

Type: Startup Activities: spacetech Technologies: New Materials

France, Belgium, Luxemburg, Switzerland​. One Team for better & healthier every day for every woman. ​ Organon, here for her health We are a global healthcare company with a portfolio of therapies and products in women’s health, biosimilars, and established brands across a wide array of conditions and diseases. ​

Type: Startup Activities: healthtech Technologies: Synthetic Biology

augmented intelligence for precision oncology research and drug development Epigene Labs is creating the intelligence-augmenting solution for precision oncology research and drug development. Designed by cancer scientists for cancer scientists, the company's mCUBE platform accelerates data-driven drug discovery, biomarker identification, and patient selection -- to bring better treatments to patients faster. Based in Paris and Boston, Epigene Labs was initially incubated at the Harvard Innovation Labs and launched in France with the support of prominent European investors. Epigene Labs has partnerships with world-class cancer research institutes and biopharmaceutical companies.

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Boosting Survival Through Innovative Immune Modulation MaaT Pharma is a leading, late-stage clinical company focused on developing innovative gut microbiome-driven therapies to modulate the immune system and enhance cancer patient survival. Supported by a talented team committed to making a difference for patients worldwide, the Company was founded in 2014 and is based in Lyon, France. As a pioneer, MaaT Pharma is leading the way in bringing the first microbiome-driven immunomodulator in oncology. Using its proprietary pooling and co-cultivation technologies, MaaT Pharma develops high diversity, standardized drug candidates, aiming at extending life of cancer patients. MaaT Pharma has been listed …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Artificial intelligence for new drug design We are a leader in artificial intelligence and robotic solutions applied to research in medicinal chemistry and new drug design. Iktos' proprietary and innovative generative AI solution enables the design of molecules that are optimized in silico to meet all the success criteria of a small molecule discovery project. The use of Iktos technology enables major productivity gains in upstream pharmaceutical R&D. Iktos offers its technology through the SaaS software platforms MakyaTM for generative drug design and SpayaTM for retrosynthesis, and through strategic collaborations with pharma companies where Iktos mobilizes its unique platform and …

Type: Startup Activities: deeptech biotech it services Technologies: A.I. - Deep Learning A.I. A.I. - Machine Learning Generative A.I.

Micropep is an innovative plant biotechnology company developing the next generation of biological crop protection solutions based on the incredible potential of micropeptides; short natural peptide molecules that target and regulate plant genes and proteins.

Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials

Transforming how molecular biology translates to human health, personalized medicine and synthetic biology DNA Script was created to revolutionize DNA synthesis with enzymes. Our core R&D efforts have produced innovations in enzyme engineering, surface and nucleotide chemistries, and instrumentation. The integration of these innovations has resulted in SYNTAXTM️, the world’s first benchtop DNA printer powered by enzymatic technology. With continued advancement and innovation, we believe DNA Script’s enzymatic DNA synthesis technology is poised to become the engine of genomics research and personalized medicine. Synthetic Biology, Biotechnology, DNA synthesis, Sciences, Research, Development, Start-up, and Technology

Tags: FrenchTech120 FrenchTech2030 Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Advanced Brain Therapy Carthera® is a clinical-stage medtech company focused on developing innovative ultrasound-based medical devices to treat a wide range of severe brain disorders. Carthera® has developed a proprietary device called SonoCloud®- a groundbreaking medical device that emits ultrasound to temporarily increase the permeability of the blood vessels in the brain. By using SonoCloud®, the therapeutic efficacy of new and existing therapies can be unlocked and harnessed to improve the treatment of a wide range of brain diseases: oncology indications (glioblastoma, brain metastasis) or neurodegenerative diseases (such as Alzheimer’s Disease, ALS). The products developed by Carthera® are in clinical …

Type: Startup Activities: healthtech deeptech Technologies: Synthetic Biology

Synthetic DNA for Health & Sustainability Twist Bioscience is a synthetic biology company based in South San Francisco, California. The company has developed a proprietary silicon-based manufacturing process for the production of synthetic DNA. Twist Bioscience serves Life Science researchers who are changing the world for the better. Coming from diverse fields of medicine, agriculture, industrial chemicals and data storage, scientists use our synthetic genes, oligo pools, and NGS target enrichment to better lives and improve the sustainability of the planet. Twist Bioscience is uniquely positioned to help accelerate these efforts by providing precision at a scale that is otherwise …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

#biopharma #biotech #drugdiscovery #GPCR #Immunooncology #inflammation Domain Therapeutics, a clinical-stage global biopharmaceutical company, focused on developing innovative immunotherapies targeting G Protein-Coupled Receptors (GPCRs), one of the most important drug target classes, to unlock new possibilities in cancer. As a leader in GPCRs in immuno-oncology, Domain sees cancer differently, using a precise biomarker strategy to address the specific needs of patients based on unique signatures of individual cancers. Two decades of solid experience in GPCR drug discovery, validated by multiple pharma partnerships, associated to a target identification and drug discovery platform enable the Company to enhance the understanding of cancer and …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Initially built out of 10 years investment in the Wellcome Sanger Institute, Microbiotica has unrivalled capabilities in microbiome analysis linked to patient phenotype. It is a global leader in gut bacterial culturing, and has a world leading microbiome Culture Collection, proprietary Reference Genome Database and advanced microbiome bioinformatics. The company also has advanced capabilities in microbiome/host biology and preclinical development of bacterial products. Microbiotica has a pipeline of highly differentiated clinically-derived products including Live Bacterial Therapeutics and Biomarkers in IBD, Immuno-oncology and Gut Epithelial Barrier Repair. It has collaborations with Cancer Research UK and Cambridge University Hospitals in Immuno-oncology, Genentech/Roche …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We fund high-risk, high-reward cancer research. We identify & enable young scientists who are brilliant, brave and bold. To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. The Foundation supports emerging leaders who have great potential to achieve breakthroughs in how we diagnose, treat and prevent cancer. To date, the Foundation has invested nearly $395 million in cancer research, supporting over 3,825 doctors and researchers. Its alumni include 13 Nobel Laureates and 86 members of the National Academy of Science (the science ‘Hall of Fame’). For more, visit …

Type: Incubators & VCs

Unleash the Potential of Genomic Medicine Using AI Founded in 2019, backed by Y-Combinator, WhiteLab Genomics stands at the convergence of computer sciences and biology, pioneering the accelerated development of genomic medicines. By leveraging their proprietary technology, WhiteLab Genomics analyzes complex biological data powered by AI to significantly reduce development timelines and mitigate associated risks. Based on exhaustive datasets, the platform provides in-silico simulations to discover, and design optimized payloads and vectors. WhiteLab aims to expedite the drug development process, cut costs, and accelerate the delivery of life-saving therapies to the market. The company collaborates with leading pharmaceutical companies such …

Tags: FrenchTech2030 Type: Startup Activities: deeptech it services Technologies: A.I. A.I. - Machine Learning Synthetic Biology

Advocate. Cultivate. Educate. Doing all things bio in the Pacific Northwest. Oregon Bioscience Association (@OregonBio) members are involved in cutting edge research and development of innovative health care, agricultural and environmental bio technologies. Our corporate members range from entrepreneurial start ups developing a first product to large multinationals. We also represent the state’s biotech research institutions, service providers to the industry and academic centers of learning. A unified voice for the Oregon bioscience community the Oregon Bio: * Represents the bioscience research to commercialization process * Helps to accelerate the growth of the biosciences industry in all parts of Oregon …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech

We represent the innovative pharmaceutical industry globally, with a focus on innovation, equitable access, and ethics. IFPMA represents the innovative pharmaceutical industry at the international level, engaging in official relations with the United Nations and multilateral organizations. Our vision is to ensure that scientific progress translates into the next generation of medicines and vaccines that deliver a healthier future for people everywhere. To achieve this, we act as a trusted partner, bringing our members' expertise to champion pharmaceutical innovation, drive policy that supports the research, development, and delivery of health technologies, and create sustainable solutions that advance global health. Biopharmaceuticals, …

Type: NGO, Think-tanks, Ed, & Culture Startup Activities: biotech deeptech Technologies: Synthetic Biology

Amplifying Scientific Innovation® The Sophia Consulting Firm LLC is a Global Scientific Storytelling Consultancy focused on Amplifying Scientific Innovation®. For more information, please visit www.sophiaconsultingfirm.com scientific communications, oncology, women's health, regenerative medicine, books, executive leadership, STEM, leadership, diversity, podcast, health equity, DEI, Health, innovation, leadership development, market research, general management, social media, AI, strategyconsulting, and medicalaffairs

Type: Media

Make Good. No Compromise.® Amyris is a vertically integrated synthetic biology company that partners with companies across industries to create, scale-up, and manufacture sustainable, market-ready ingredients utilizing advanced fermentation technology and world-class platforms. Leveraging two decades of experience, we innovate at an unparalleled rate. Our flexible collaboration models enable us to partner with companies at a variety of growth stages to facilitate sustainability and economic objectives while eliminating supply chain obstacles. Our renewable and traceable ingredients are already proven game-changers for the industrials, pharmaceuticals, flavors and fragrances, and beauty, health and wellness industries and are included in thousands of products, …

Type: Large company

Revolutionizing in vivo gene delivery to usher in a new era of genetic medicines. Kelonia is pioneering a new wave of genetic medicines using its next generation gene delivery platform. The company’s simple and elegant cutting-edge in vivo gene delivery technology uses a few potent lentiviral vector-like particles to precisely and efficiently deliver in vivo genetic cargo to the desired target tissue, and only that tissue, every time. With an initial focus on developing transformational therapies for solid tumors and hematologic cancers, Kelonia is building a pipeline of genetic medicines for a wide range of diseases, with the bold goal …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Using AI and Photonics to enable a new era of personalized, precision medicine. iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development. Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster. Recognized by CB Insights as one of the top Digital Health companies in the world and by the Financial Times as a Transformational Business in Healthcare, iLoF is supported …

Type: SMB Activities: biotech deeptech Technologies: A.I. Data Analytics

API manufacturer of small quantities and GMP excipients supplier Founded in 2000, DIVERCHIM is the leading French company for organic synthesis of original molecules bringing its customers a top level expertise. DIVERCHIM is a Contract Research Organisation (CRO) in organic chemistry. Our teams combine experience in drug discovery and process development, medicinal chemistry, parallel synthesis, biochemical tools and fine chemicals to deliver you with unique chemistry solutions to achieve your requirements. Diverchim specifies in complex multi-steps synthesis, low temperature chemistry, asymmetric, organometallic, cyclopropane, pyrrolidine, oxetane chemistry... Besides Diverchim can scale-up existing processes or develop a new process for existing products. …

Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology

Ability Pharmaceuticals is a clinical-stage biopharmaceutical company committed to develop first-in-class therapies that address unmet medical needs in the oncology space. AbilityPharma's is currently conducting, with ABTL0812, the most advanced asset, an international multi-center, double-blind, placebo-controlled phase 2b clinical trial in patients with metastatic pancreatic cancer to investigate ABTL0812 as first-lin therapy in combination with FOLFIRINOX chemotherapy. The study includes reference centers in Spain, France, United States and Israel. ABTL0812 has finished with very positive results a phase 2a clinical trial as first-line therapy in endometrial cancer and in squamous NSCLC in combination with paclitaxel and carboplatin. The study included …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Digital bio-solutions designed to support the development of biomedicines and optimize their prescription. mYXpression is an innovative French company positioned in the field of health innovation. The company, specialized in R&D, develops innovative tools to assist in the prescription of biomedicines. Its first tool, the RITI® RA test, provides a personalized report specific to the patient by indicating an efficacy score for each biotherapy. This brand new approach provides numerous useful insights to the doctor by assisting in the prescription of biotherapy in order to increase the patient's chances of remission. bio-numérique, innovation technologique, big data, bio-technologie , biotherapie, intelligence …

Type: Startup Activities: biotech deeptech healthtech Technologies: A.I.

Your service provider in histology Since 1996, Novaxia is an independent laboratory offering customized services in histology. Whether you are a private or public research center, Novaxia accompanies you in your development projects. We work according to Good Laboratory Practices (G.L.P. Accreditation by the relevant French authority : ANSM). The range of services offered extend beyond classical histology, since today Novaxia offers services such as immunohistochemistry (IHC) and slide digitization. Our first priority is to put our knowledge and skills at your disposal. We want to understand your scientific question to ensure that we fully meet all of your expectations. …

Type: SMB Activities: deeptech Technologies: Synthetic Biology

Immunotherapy against cancer. 4 clinical-stage products. 2 novel platforms: Invir.IOTM and myvac® Cancer immunotherapy Transgene (Euronext: TNG) is a biotechnology company focused on designing and developing novel immunotherapies for the treatment of cancer.

Type: SMB Activities: deeptech biotech

Evexta Bio, formerly #Diaccurate, is a biopharmaceutical company exploring the new frontiers of #oncology in search of daring novel therapeutic approaches with the potential to save lives. Now in the clinic, the French biotech is currently developing two proprietary therapeutic assets with novel mechanisms of action across several indications: - Rupitasertib, formerly DIACC3010, an optimized S6K inhibitor with efficient AKT1/AKT3 control of feed-back loop. The oral anti-tumor agent is expected to enter phase 2/3 clinical trial in refractory ER+ HER2- metastatic breast cancer. - EVX020, formerly DIACC2020, an antibody-drug conjugate program using a sole-in-class KIF20A kinesin inhibitor as payload in …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

We use fruit flies to help scientists change the world. Future Fields is a fly biotechnology company based in Edmonton, Canada. Founded in 2018, Future Fields is on a mission to change how we do science for humanity and the planet. Our biomanufacturing platform, the EntoEngineTM, is the first synthetic biology system in the world to use fruit flies for recombinant protein production. Powered by people and fly by design, we’re equipping industries with the biomolecular tools they need to sustainably, ethically, and economically conduct great science. Future Fields is a proud business member of 1% for the Planet, a …

Type: Startup Activities: agritech Technologies: Synthetic Biology

Barinthus is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutic candidates. Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Original genetic technologies using bacteriocins. Syngulon is a synthetic biology startup developing original genetic technologies using bacteriocins. Our team of scientists works in different academic laboratories and our R&D programs involve partners from Belgium, Spain, France, Switzerland, The Netherlands, and the UK. We think of ourselves as a “Startup in the Labs”, meaning that we work directly in the labs of our academic partners. The members of our Scientific Advisory Board are active in Belgium, France and the USA. The mission of Syngulon is to provide genetic technologies that make microbial strains involved in industrial processes safer and more efficient. …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Powering the patient’s immune system to cure cancer TILT Biotherapeutics Ltd is a clinical stage company working in oncology towards enabling T-cell therapies and immune checkpoint inhibitors with oncolytic viruses. Embodiments of the technology will be used to enhance tumor infiltrating lymphocytes (TILs), chimeric antigen receptor T cells (CAR T) and immune checkpoint inhibiting antibody therapies. TILT was founded by Pr. Akseli Hemminki, who has published hundreds of papers in the field and treated almost 300 patients with 10 different oncolytic viruses. In 2013, Pr. Hemminki started his second company, TILT Biotherapeutics Ltd, with a technology based on his past …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Dalan's novel platform technology has introduced the world's first-ever honeybee vaccine, marking a pivotal milestone for the industry. Our mission is to safeguard the planet’s most underserved animal species, ensuring their continued well-being for global food security and the overall health of our planet.

Type: Startup Activities: pettech healthtech biotech Technologies: Synthetic Biology

Economic development agency for Occitanie, France. We help Occitanie companies successfully enter the U.S. market. Maison de la Région Occitanie / Sud de France New York is an economic development agency for the Occitanie region in France. We guide Occitanie companies through their exporting process to the U.S. market as well as help North American companies develop and invest in the Occitanie region.

Type: Incubators & VCs

Mastering the microbiome, transforming lives® EnteroBiotix is a leading microbiome therapeutics platform company that is focussed on transforming the standard of care for patients battling debilitating diseases and infections linked to disruptions to structure and function of the gut microbiome.

Type: Startup Activities: deeptech biotech healthtech Technologies: Synthetic Biology

Octavian develops non-addictive small-molecule medicines targeting the ECS to revolutionise precision pain management. Octavian is at the frontier of precision pain management, developing innovative, non-addictive, small-molecule medicines that target the endocannabinoid system (ECS) to address the global challenge of chronic pain, which affects over 1.5 billion 1 people and drives dangerous dependence on opioids.

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Collaborating in the Fight for Health The Partnership to Fight Infectious Disease (PFID) is a group of patients, providers, community organizations, business and labor groups, and health policy experts working to advance awareness and action on antimicrobial resistance. As an initiative of the Partnership to Fight Chronic Disease, PFID is focusing on the impact of this growing issue on our population and health care system. In particular, we will explore and advance solutions to address the threat of antimicrobial resistance and the need for new antimicrobial treatments.

Type: NGO, Think-tanks, Ed, & Culture Activities: healthtech

We’re the world’s leading business voice on aging-related policy and strategy. The Global Coalition on Aging (GCOA) aims to reshape how global leaders approach and prepare for the 21st century’s profound shift in population aging. Through research, public policy analysis, advocacy and strategic communications, GCOA is advancing innovative policy and market solutions and working to ensure global aging is a path to health, productivity, and economic growth.

Type: NGO, Think-tanks, Ed, & Culture Activities: consulting

Empower Your Mind, Balance Your Energy, Transform Your Life Biotech Developments

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Unearth Answers in Microgravity for Humanity Space Tango is an industry leader in automated systems in the pursuit of health and technology manufacturing in space. Since 2017 through a NASA Space Act Agreement, Space Tango provides facilities to support iterative R&D and manufacturing in space. Through an integrated and intuitive approach, Space Tango works alongside its diverse partner base to embrace pathways to on-orbit production yielding valuable and transformational solutions for humanity. Space Tango believes the microgravity environment is a new frontier for discovery and innovation. We are focused on creating a new global market 250 miles up in low …

Type: Startup Activities: spacetech Technologies: Synthetic Biology

Pioneering first-in-class, small-molecule therapies for immune-mediated and oncologic disorders We are a clinical-stage biotechnology company combining courage, conviction and cutting-edge science to develop breakthrough treatments for immune-mediated and oncologic disorders, with the hope of helping patients overcome their disease and live a better life. We are pioneering first-in-class, small-molecule therapies that harness master regulators of cellular function and inhibit multiple drivers of disease via a single target. In modulating the function of profound intracellular regulators, our medicines have the potential for significant clinical impact in the most difficult-to-treat diseases. We believe the wide-ranging impact of our therapeutic platforms can be …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Revolutionizing the Delivery of Healthcare. Biofourmis brings the right care to every person, no matter where they are. The company’s AI-driven solution collects and analyzes over 120 biomarkers in real time and identifies shifts that require proactive interventions. This vital innovation enables Biofourmis to offer people everywhere connected access to hospital-level services, virtual provider networks for remote care, and life-changing clinical trials—all without leaving their homes. Trusted by leading health systems, payers, biopharma companies and patients alike, Biofourmis’ connected platform improves patient outcomes, prevents hospitalization readmissions, accelerates drug development, and closes critical gaps in care—with the goal of making science …

Type: Startup Activities: deeptech biotech healthtech Technologies: A.I. Data Analytics

Advancing agriculture in the states. Founded in 1916, NASDA is a nonpartisan, nonprofit association which represents the elected and appointed commissioners, secretaries, and directors of the departments of agriculture in all fifty states and four U.S. territories. NASDA grows and enhances agriculture by forging partnerships and creating consensus to achieve sound policy outcomes between state departments of agriculture, the federal government, and stakeholders. To learn more about NASDA, please visit www.nasda.org.

Type: NGO, Think-tanks, Ed, & Culture Activities: agritech

The Trusted Source for Executive Intelligence Equilar is the leading provider of executive intelligence solutions. The company’s expertise in relationship intelligence drives state-of-the-art business development and CRM applications, board and executive recruitment, and compensation and governance strategies. Equilar integrates its extensive database of executive profiles with natural language processing and machine learning AI to enable real-time relationship analytics and targeted outreach for its global clients. Equilar's commitment to excellence has made it the go-to solution for over 1,000 companies, including 75% of the Fortune 500, top PE/VC firms, and leading professional services entities. Learn more at www.equilar.com. Human Resources, Shareholder …

Type: SMB Activities: hrtech Technologies: Data Analytics

Intellectual property law is continuously evolving. Sunstein is at the forefront. Sunstein LLP is a boutique Intellectual Property firm with a 40-year history of success and expertise in all areas of IP law including litigation, patent and trademark prosecution, intellectual property portfolio development and business transactions. IP law is rapidly evolving and Sunstein has been at the forefront of these changes. Law firm, IP firm, Intellectual Property, Patent, Copyright, and Trademark

Type: SMB Activities: legaltech

Animal Medical Imaging Services Voxcan is a CRO specialized in non-invasive high-resolution imaging for non-clinical drug development, based in Lyon, France.Voxcan’s core businesses have been in oncology, viral and bacterial infectious diseases, osteo-articular inflammatory diseases and medical devices for 16 years, performing efficacy, biodistribution, mechanistic and proof of concept studies based on in vitro and in vivo models combined with high-resolution imaging in a wide range of small animal species. Voxcan joined the ERBC group in July 2023, giving access to its clients to a full range of non-clinical expertises. This acquisition is in line with ERBC's 3R policy and …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Your Global Life Science Solutions Partner Founded in 1996, PSC Biotech Corporation was created with the vision of providing life science companies unmatched support. PSC Biotech Corporation serves 1000 clients in more than 35 countries worldwide through professional services consulting, cloud-based software solutions, pharmaceuticals contract manufacturing, life science investment consulting, and metrology services. PSC Biotech Corporation has three unique divisions within the parent company – each representing one of our areas of expertise: PSC Biotech, PSC Software, and BioTechniqueTM. Additionally, PSC Asia and PSC Biotech Ltd represent PSC Biotech Corporation in Asia and Europe, respectively. Together, these divisions enable us …

Type: SMB Activities: biotech deeptech it services Technologies: SaaS

JPEO-CBRND: Providing the warfighter with the best CBRN defense technology, equipment and medical countermeasures Welcome to the official Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense (JPEO-CBRND) LinkedIn page. Our mission is to provide the warfighter with the best CBRN defense technology, equipment, and medical countermeasures at the right cost, at the right time, and at the right place. For more information, visit https://www.jpeocbrnd.osd.mil/ MISSION Provide integrated layered Chemical, Biological, Radiological, and Nuclear defense capabilities to the Joint Force across warfighting functions and combined Joint All-Domain Operations VISION A resilient Joint Force enabled to fight and win …

Type: Public

Follow Astellas Pharma for updates on our pipeline of genetic medicines for patients with rare diseases. The Astellas Gene Therapies page is no longer active or monitored. gene therapy and biotechnology

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

connecting the life sciences community The Virginia Biotechnology Association (Virginia Bio), formed in 1992, is the premier statewide non-profit trade association representing the life sciences industry in the Commonwealth of Virginia. More than 200 member organizations have joined forces to make Virginia Bio an effective advocate for the biopharmaceutical and device industries before federal, state and local policy-makers. Virginia Bio is the official state affiliate of the Biotechnology Industry Organization (BIO), in Washington, D.C. Professional service firms, research labs and all manner of bioscience companies are welcome to participate. To join Virginia Bio, please visit us at www.vabio.org, on X …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech

Delaware's Must-Read Source for Business News. Using multiple platforms, Delaware Business Times provides timely, informative content to tens of thousands of decision-makers across the First State. From breaking news coverage and in-depth reporting to hosting networking and premier recognition events, Delaware Business Times has been connecting its readers with marketers for over a decade. Today Media is a multi-platform communications company providing content that attracts hundreds of thousands of loyal consumers each day and offers marketers advertising solutions in print, online, and in person. In addition to Delaware Business Times, Today Media publishes Delaware Today, Main Line Today, Westchester Magazine, …

Type: Media

🖇️ Oncofactory, a spin-off of the CNRS, is a science-driven biotech company that provides pharmaceutical and biotech companies with innovative in vivo services to support their non-clinical programs in oncology. Oncofactory joined the ERBC Group in December 2022 to extend its technology to a wider range of customers and provide a one-stop shop for non-clinical studies. 🥚Oncofactory unique technology platform is a New Approach Methodology (NAM) to generate patient tumor replicas in avian embryos (AVI-PDXTM), coupled with state-of-the-art 3D imaging and large-scale molecular analysis for rapid assessment of therapeutic efficacy and in-depth characterization of mechanisms of action to evaluate therapeutic …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Making biology easier to engineer. At Ginkgo, we use biology to grow the future. Companies across industries leverage our platform to design, develop, and optimize products for a breadth of commercial applications. We help our partners grow key ingredients for vaccines, crops that rely less on fossil fuel-based fertilizers, plant-based meat that tastes like the real thing, materials for the next generation of circular fashion, and so much more. We know our unique experiences, ideas, and perspectives are essential to our success and enable us to make biology easier to engineer and ensure equitable distribution of the benefits of our …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology SaaS

NewYorkBIO supports the development and growth of New York State’s life science industry. NewYorkBIO supports the development and growth of New York State’s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development.

Type: Incubators & VCs

We are Cytovance Biologics, your responsive, reliable, and resourceful CDMO Partner. Welcome to Cytovance Biologics! Born from a decades-long history in drug development, we believe in creating a healthier world where every biologic’s path to commercialization is advanced by a CDMO partner that delivers ingenuity end-to-end. Whether your large molecule product needs the flexibility of a customized approach or the efficiency of a predetermined platform process, Team Cytovance has the deep expertise in microbial and mammalian expression systems to support your scale-up at every stage. From early needs like cell line development and strain selection to cGMP manufacturing for clinical …

Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology

Building a healthier world through better fruits and vegetables Pairwise is a start-up food company that uses technology to break down the barriers that keep us from eating produce. At Pairwise, we are passionate about building a healthier world through better fruits and vegetables. Headquartered in Durham, NC, our team is made up of leaders in R&D, agriculture, and consumer products. Founded in 2017 and opened in 2018, Pairwise is working to deliver breakthrough innovation in agricultural sciences and in healthy consumer foods. Our team of proven leaders features Dr. Tom Adams, Chief Executive Officer (CEO), Dr. Haven Baker, Chief …

Type: Startup Activities: foodtech

A global advisory and strategic communications firm at the nexus of influence and capital Qorvis is a global advisory and strategic communications firm headquartered in Washington, D.C., with primary offices in Geneva and Dubai. Standing at the nexus of influence and capital, we leverage our rich 20-year history to help the world’s most recognizable brands navigate the headwinds of a rapidly changing stakeholder economy and anticipate what’s next in the increasingly volatile geopolitical landscape. We have the reach and resources to deliver clear and actionable strategies to optimize brand performance, accelerate growth, secure capital and influence outcomes in the markets …

Type: SMB Activities: consulting govtech martech

Together, we can make a lasting impact on global health – and your business. We’re Rabin Martin, a team of global health impact consultants. Driving better outcomes, access and equity – from strategy to execution. ​ We design, develop and deliver effective solutions to unlock new markets and opportunities – creating creative ways for more people to access our client's medicines and vaccines, and generating support among key stakeholders. ​ In today’s competitive and complex healthcare environment, leveraging Global Health expertise and partnerships, from strategy to execution, is a must-have in unlocking incremental growth. To do this, we bring together …

Type: SMB Activities: consulting Technologies: Synthetic Biology

Business France and its partners: promoting and supporting foreign investment in France Creators of business opportunities, throughout the world 🌍 International development is key to the development of your business. What if a meeting with Business France was what you needed to give your projects a new dimension? Our three flagship professions all have one thing in common: boosting you on the global stage!  To fast-track exports, we make the daily lives of entrepreneurs easier by providing them with the power of our network.  To generate investments and employment in France, we promote the economic attractiveness of our …

Type: Public

A Member of the Roche Group Poseida was acquired by Roche in early 2025 and is now part of the Roche Group. Poseida is a clinical-stage biopharmaceutical company advancing differentiated allogeneic cell therapies and genetic medicines with the capacity to cure. The Company's approach is based on its proprietary genetic editing platforms, including its non-viral DNA Delivery System, Cas-CLOVERTM Site-Specific Gene Editing System, Booster Molecule and nanoparticle gene delivery technologies, as well as in-house GMP cell therapy manufacturing. Genome Engineering, CAR-T cells, Gene Therapy, Gene Editing, Cell Therapy, Adoptive Cell Therapy, Multiple Myeloma, Prostate Cancer, Transposon, Non-viral, Biotechnology, Immunotherapy, Regenerative …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

MindMed is a clinical-stage biopharma company developing novel products to treat brain health disorders MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to improve patient outcomes. We are developing a pipeline of innovative drug candidates, with and without acute perceptual effects, targeting the serotonin, dopamine and acetylcholine systems. MindMed trades on the NASDAQ under the symbol MNMD and on the Canadian NEO Exchange under the …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

Sonata Therapeutics is a new, Boston-based Flagship Pioneering company revolutionizing the world’s understanding of the cellular microenvironment and its importance to human biology and disease. Our product-platform creates drugs based on a systematic, comprehensive characterization of the microenvironment in diseases with high unmet medical need. Through our pioneering science, we identify new targets for therapeutics that induce the release of a programmed diversity of signals with the potential for significant patient impact. Our employees are exceptionally passionate, accountable, collaborative, and innovative. Sonata Therapeutics was founded by Flagship Pioneering, an organization dedicated to the origination and development of first-in-category life sciences …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Daring to be different Daré Bioscience® (NASDAQ: DARE) is a clinical-stage biopharmaceutical company committed to the advancement of innovative products for women's health. With eight potentially first-in-class women’s health products in development, we are committed to bring to market differentiated products designed to expand treatment options, improve outcomes, and facilitate a better quality of life for women. Vaginal drug delivery is often the optimum delivery approach to achieve these objectives, and IVR technology has become one of our preferred investigational platforms. Our portfolio features innovative IVR technologies including our non-hormonal contraceptive Ovaprene®, which we believe has the potential to disrupt …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Representing the corn refining industry and safe and affordable corn products since 1913. The Corn Refiners Association (CRA) is the national trade association representing the corn refining industry of the United States. CRA and its predecessors have served this important segment of American agribusiness since 1913. CRA advocates for science-based public policy and economically-sound decisions at the state, federal, and global levels. It approaches every new challenge with its members and their customers in mind, working to foster technological innovation, expand commercial opportunities, advance free trade, build the bioeconomy, and feed a hungry world. ABOUT THE INDUSTRY: Corn refiners manufacture …

Type: NGO, Think-tanks, Ed, & Culture Activities: foodtech Technologies: Bio sourced materials

Recycling carbon with biology Our way of life is built on carbon, from our fuel sources to the materials in our consumer products, but we need a more sustainable way to source it to protect the future of our planet. LanzaTech Global, Inc. is the carbon recycling company transforming waste carbon into sustainable raw materials for everyday products. Using its biorecycling technology, LanzaTech captures carbon-rich gases generated by energy-intensive industries at the source, preventing them from being emitted into the air. LanzaTech then gives that captured carbon a new life as a sustainable replacement for virgin fossil carbon in everything …

Type: SMB Activities: cleantech greentech Technologies: Decarbonization

Blockchain-based traceability for the whole supply chain A blockchain based traceability solution built to enable trust, coordination, and transparency in fragmented global supply chains. traceability, food systems, seafood, agriculture, whole chain, supply chains, blockchain, data sharing, supply chain incentives, trade finance, food safety, sustainability, visibility, transparancy, and proteins

Type: Startup Activities: transporttech Technologies: Blockchain/Cryptocurrency

To promote, connect and engage the life sciences community The Illinois Biotechnology Innovation Organization (iBIO) is a life sciences industry association of more than 500 members comprised of life sciences companies, universities, academic institutions, service providers and others dedicated to making Illinois and the surrounding Midwest one of the world’s top life sciences centers. We drive industry growth by creating a forum for the life sciences community to come together, educating the public and policy makers, influencing public policy and advancing the economic interests of the community. iBIO’s members range from small startups to global corporations. They work in the …

Type: NGO, Think-tanks, Ed, & Culture Activities: deeptech biotech healthtech Technologies: Decarbonization

Team of specialized thinkers and executors in health and science innovation. Global Alliance with Omnicom PR Group LaVoieHealthScience provides strategic communications programs that integrate public and investor relations, marketing and communications to engage target stakeholders to create behavioral change. Our focus is on building value for health science innovations. Through our alliance with Omnicom Public Relations Group, we bring high-touch service with the global scale of 2,000 health expert consults across 100 countries. We help our clients create awareness, gain recognition and optimal value for their initiatives, technologies, products and businesses. Our expert team of investor relations and public relations …

Type: Media SMB Activities: healthtech consulting deeptech biotech

The Human-on-a-Chip Company Hesperos, Inc. is accelerating drug discovery by providing safety and efficacy testing of chemicals and novel therapeutics for the pharmaceutical, cosmetic, and food industries using its patented, Human-on-a-Chip platform. Bringing together biologists, surface chemists, and engineers, our team is producing some of the world's most advanced organs-on-a-chip platforms. From gene expression to electrophysiology, we recreate key components of organs in an interconnected, functional system. Chemically patterned microchips enable real-time, non-invasive monitoring of organ function where we use sophisticated measurement techniques to detect minute changes. This breakthrough technology enables unprecedented visibility into specific disease states and how the …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology

The trade association giving a bigger voice to small and mid-sized innovative health technology companies in Europe For 15 years, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) has been the voice of small to mid-sized health technology companies in Europe. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through innovative therapies and medical technology. EUCOPE’s members – who represent over 2600+ innovative companies directly or via associations – are researching, designing, developing, supplying, manufacturing, and deploying the next …

Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech

Jobs. Skills. Investment. Investment NSW has a mandate to deliver on the NSW Government’s priorities to build a strong economy, attract local and international investment and help NSW businesses find new export markets. Working across key industries, our aim is to reinforce NSW’s global position as a safe and attractive place to do business and accelerate investment in priority sectors such as Net Zero, Technology, Advanced Manufacturing, International Education, Med Tech and Life Sciences, Agri-business and Defence and Aerospace. NSW is open for business. Large or small, international or domestic, now is the time for investors to capitalise on all …

Type: Public

Artificial Intelligence, High Performance Computing, and RNA sequencing data to find cures faster than ever before. Envisagenics was founded in 2014 as a spinout of Cold Spring Harbor Laboratory. Our mission is to reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions through RNA splicing analytics and artificial intelligence. We focus on the discovery of RNA therapeutics. Over 30 million people in the US suffer from genetic diseases or cancer that could be caused by mutations affecting RNA splicing. 370 human diseases are known to be caused by splicing errors, and more remain to be …

Type: Startup Activities: biotech deeptech Technologies: A.I. - Deep Learning A.I. A.I. - Machine Learning

Process & Technology innovations for biobased solutions to food, feed, chemicals, biomaterials and bioenergies Brussels, BELGIUM -- May 11-13, 2025 -- Biomass is a wonderful ressource to be transformed into chemicals, biobased materials, food and feed ingredients or energy. Still, adaptation and optimisation of transformation processes and technologies is a real challenge in order to valorise all biomass fraction in a circular approach. In the context of Industry 4.0, the circular economy and the need for an optimal valorization of renewable resources, BIOKET is the only European conference dedicated to bio-based technologies and processes. Innovative Processes, Biotechnology, Green Chemistry, Polymerisation, …

Type: NGO, Think-tanks, Ed, & Culture Activities: cleantech greentech

Striving to improve and extend patients' lives Blueprint Medicines is a global, fully integrated biopharmaceutical company that invents life-changing medicines. We seek to alleviate human suffering by solving important medical problems in two core focus areas: allergy/inflammation and oncology/hematology. Our approach begins by targeting the root causes of disease, using deep scientific knowledge in our core focus areas and drug discovery expertise across multiple therapeutic modalities. We have a proven track record of success with two approved medicines in the U.S. and Europe. Leveraging our established research, development, and commercial capability and infrastructure, we now aim to significantly scale our …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

A network connected to its time, businesses, missions, partners and Air-Mer-Terre natural elements The CCI Midi-Pyrénées acts for the economic development of the region, alongside companies. Place of consultation and coordination of the eight territorial chambers, the CCI Midi-Pyrénées carries out specific common actions with them. The consular network has developed multiple services for companies, from creation to sale or transmission. He is also an interlocutor of choice for students and assets looking for training. In 2015, the Midi-Pyrénées CCI network supported 140 companies in their energy saving approach, 3000 buyers creators and formed 1200 apprentices. Services, Creation, Transmission, Resumption, …

Type: Public

BigHat Biosciences is a novel protein therapeutics company and developer of an AI-guided antibody design platform BigHat’s mission is to improve human health by making it far easier to design advanced, next-generation antibody therapeutics. Our AI-enabled experimental platform integrates a high-speed characterization or “wet” lab with machine learning technologies to speed the antibody engineering process. When applied, these design capabilities have the potential to drive the development of new generations of safer and more effective treatments for patients suffering from today’s most challenging diseases. BigHat is backed by Section 32, ‍Andreessen Horowitz, 8VC, Amgen Ventures, Bristol Myers Squibb, Quadrille, Grids …

Type: Startup Activities: biotech deeptech it services Technologies: A.I. Synthetic Biology SaaS Generative A.I.

Your partner in aseptic filling and packaging We turn active ingredients into medicine. As one of the leading pharmaceutical service providers for the aseptic manufacture of injectable medicines, we are a global player – and a family business. Together with our 7,000 employees, we help improve the lives of people around the world. We combine tradition and innovation in a job that has meaning. Ravensburg is where our roots are. We make a significant contribution to reliably supplying patients with medicines from our state-of-the-art production sites in Europe and the United States. We work hand in hand with pharmaceutical and …

Type: Large company

Focused on the development & commercialisation of innovative medicines. Ticker: POLB Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation. Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value. The team has been strengthened by the appointment of three former members of the …

Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology A.I.

Locus Biosciences, Inc. is a biotechnology company that develops precision, engineered bacteriophage products. Locus Biosciences is a clinical-stage biotechnology company developing engineered bacteriophage products to address critical unmet medical needs in bacterial infections and immunology. The LOCUS platform combines predictive artificial intelligence and automated robotics to deliver optimized precision phage therapies that specifically kill target pathogens while leaving non-target bacteria (i.e., the rest of the patient’s microbiome) unaffected. Locus has strong backing from partners, having signed contracts with BARDA and CARB-X. The company recently completed the open-label portion of a Phase 2 trial assessing LBP-EC01 for the treatment of uncomplicated …

Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology

Make informed choices about your health. Our MOBILIZETM platform highlights issues affecting global healthcare. Medika Life is an online health information platform dedicated to bringing scientifically-validated and actionable health information to the world. We focus on promoting the voices of healthcare practitioners from within the industry. Our MOBILIZETM Medicine platform addresses global and local issues affecting the delivery of basic healthcare to all communities. We are outspoken in terms of equality, both within the industry - from a professional perspective - and in the delivery and accessibility of services. Our articles, mostly written by colleagues across the medical spectrum, are …

Type: Startup Activities: healthtech Technologies: SaaS

Expanding the economic bounds of humankind. Low Earth orbit is open for business. Varda is accelerating the development of commercial space infrastructure, from in-orbit pharmaceutical processing to reliable and economical reentry capsules. Reusable rockets have lowered the cost of access to space and opened up a range of in-space activities. Now that access to space is cheap, it’s what we do there that counts. From new, life-saving pharmaceuticals to more powerful fiber optic cables, there is a world of products used on Earth today that can only be manufactured in space. Varda is accelerating innovation in the orbital economy and …

Type: Startup Activities: spacetech Technologies: New Materials

Promoting Diversity and Inclusion for All Women in the Life Sciences Women In Bio is an organization of professionals committed to promoting careers, leadership, and entrepreneurship of women in the life sciences. We aim to help women achieve the highest levels of leadership, influence and decision-making that they desire. Our primary focus is to provide women-to-women mentorship and leadership support through all stages of career development from bench to boardroom from academia to industry from first job to last from idea to entrepreneur Our members reflect the increasing spread of the life sciences. We belong to biotech and pharma companies, …

Type: NGO, Think-tanks, Ed, & Culture Activities: edtech

The RNA Biomarker Company. Genialis, the RNA biomarker company, is creating a world where healthcare delivers the best possible outcomes for patients, their families, and their communities. Genialis develops and validates clinically actionable biomarkers informed by the world’s most ethnographically diverse cancer data sets to better predict patient responses and guide treatment decisions for targeted inhibitors, immunotherapies, and other emerging therapeutic classes. Genialis is trusted by pharma and diagnostics partners, and together, we are transforming medicine through data. Data Fusion, Machine Learning, Biomedical Data Analysis, Omics Data Integration, Precision Medicine, Software Development, Data Visualization, Gene Signature, and Predictive Biomarker

Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning Data Analytics

Pioneering digital #biomarkers of neurological disease using augmented reality and machine learning. Altoida is a pioneer in developing digital biomarkers of neurological conditions, including Alzheimer’s Disease, using augmented reality and machine learning. Our technology platform is designed to enable an objective evaluation of an individual’s cognitive health and function, which may potentially allow for faster and more sensitive monitoring of disease progression and treatment response. Altoida is a privately-held, venture-backed, commercial stage company and our proprietary evidence-based platform is founded on more than 20 years of scientific research and published in multiple peer-reviewed papers including Nature Digital Medicine. Digital Health, …

Type: Startup Activities: healthtech deeptech Technologies: Affective Computing A.I. A.I. - Machine Learning VR

We help international companies set up successful business operations in Western Switzerland. Greater Geneva Bern area (GGBa) is the official investment promotion agency for Western Switzerland. Its mission is to support foreign companies so that they can quickly establish and develop their operations in Western Switzerland. Its services include: providing information on business environment, taxation, operational costs and labor law; facilitating contacts with peer companies and industry groups; evaluating the best location for each company’s needs and finding suitable premises. This support is provided at no charge and on a confidential basis. Since its creation in 2010, GGBa has successfully …

Type: Public Activities: fintech

The economic promotion agency for Greater Montréal. We are the official economic development and promotion agency for the Montréal region. Whatever projects you may be planning—investment, setting up or expansion—we are there to welcome you and help you succeed. Our services are free and confidential. Profiting from both its European and North American heritage, Greater Montréal is unique among North American metropolises in that it actively leverages creativity as an economic, social and cultural driving force. It is also the only metropolis to offer businesses an ideal combination of factors that are key to success: competitive operating costs, direct access …

Type: SMB Activities: fintech

“Inspiring Minds Advancing Science” Life Sciences BC is a not-for-profit, non-government, industry association that supports and represents the life sciences community of British Columbia through leadership, facilitation of investment and partnering, advocacy, and promotion of our world-class science and industry. Biopharmaceuticals, Medical Devices, Medical Technologies, and Digital Health Care

Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology

SMART. VIBRANT. ENTREPRENEURIAL. The City of Fishers is a suburb of Indianapolis, Indiana, located in Hamilton County, and is consistently nationally ranked as a top place to live. Under the leadership of Mayor Scott Fadness, Fishers is known as a smart, vibrant, and entrepreneurial city through its neighborhood development, dedication to supporting high-growth companies, and innovative city processes. With a population of 101,171 (2021, U.S. Census Bureau). Fishers is one of the fastest growing communities in Indiana and has received national accolades for entrepreneurship, livability, and safety. With a population of 91,832 (2017), Fishers is one of the fastest growing …

Type: Public

Empowering Innovators Globally | Workspace, Labs, Event Space, Community CIC is the global leader in driving innovation at scale. Founded in 1999, CIC manages more than 1.5M square feet of workspace, laboratories, and event space across North America, Europe, and Asia. Additionally, CIC develops bespoke programming, builds and enables industry clusters, and provides world-class district consulting—all focused on advancing innovation. Learn more at cic.com. office space, coworking, laboratories, innovation, startups, and real estate

Type: Incubators & VCs